Company Filing History:
Years Active: 2025
Title: Ha T Do: Innovator in Neuronal Nitric Oxide Synthase Inhibitors
Introduction
Ha T Do is a prominent inventor based in Evanston, IL (US). She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that target neuronal nitric oxide synthase (nNOS). Her work is crucial for addressing various neurological disorders.
Latest Patents
Ha T Do holds a patent for "Potent and selective human neuronal nitric oxide synthase inhibitors." This patent discloses 2-aminopyridine derivative compounds that serve as inhibitors of nitric oxide synthase (NOS). The invention specifically focuses on these compounds for use in treating diseases and disorders associated with nNOS, including Alzheimer's, Parkinson's, Huntington's diseases, amyotrophic lateral sclerosis, cerebral palsy, stroke/ischemic brain damage, and migraine headaches.
Career Highlights
Ha T Do is affiliated with Northwestern University, where she conducts her research and development work. Her innovative approach to drug formulation has the potential to significantly impact the treatment of various neurological conditions.
Collaborations
Ha T Do collaborates with Richard B Silverman, who is also a notable figure in the field of pharmaceutical sciences. Their partnership enhances the research and development of effective treatments for neurological disorders.
Conclusion
Ha T Do's contributions to the field of neuronal nitric oxide synthase inhibitors represent a significant advancement in the treatment of serious neurological diseases. Her work continues to inspire future innovations in pharmaceutical research.